The Trump administration has finalized several changes in Medicare Advantage (MA) and Part D in anticipation of bid submissions on June 1.

As an unprecedented catastrophe unfolds in which more than 28,000 people have died of Covid-19 in care facilities, the nursing home industry is responding with an unprecedented action of its own: Using its multi-million dollar lobbying machine to secure protections from liability in lawsuits.

A few short months ago, buoyed by a robust economy, U.S. states anticipated little to no growth in Medicaid spending.

Hospitals around the country are afraid to send out hundreds of thousands of bills related to COVID-19 testing. That’s because Congress mandated there would be no copays and no out-of-pocket costs for patients. But many employers with self-funded health plans seem to believe they’re exempt from the rules.

The Trump administration’s new strategy for coronavirus testing puts much of the burden on states while promising to provide supplies such as swabs and material to transport specimens.

The Trump administration announced a grant to AstraZeneca, which has licensed a potential vaccine that is in trials by Oxford University.